Evidence map›Paper›PMID 39143086›Full record

ArticleNPJ microgravity2024

Simulated microgravity impairs human NK cell cytotoxic activity against space radiation-relevant leukemic cells.

Bradford M Kuhlman, Jonathan H Diaz, Trang Simon, Kimberly D Reeves, Stephen J Walker, Anthony Atala, Graça Almeida-Porada, Christopher D Porada

Abstract read
In one paragraph

Article in NPJ microgravity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Bradford M KuhlmanWake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
Jonathan H DiazWake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
Trang SimonWake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
Kimberly D ReevesWake Forest Center for Precision Medicine, Winston Salem, NC, USA.
Stephen J WalkerWake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
Anthony AtalaWake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.ORCID http://orcid.org/0000-0001-8186-2160
Graça Almeida-Porada *Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA.
Christopher D Porada *Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, USA. cporada@wakehealth.edu.ORCID http://orcid.org/0000-0002-7321-7556

Funding

Studies in Translational Regenerative MedicineT32EB014836 · NIBIB · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI ANTHONY ATALA, Victoria Weis · 2013 to 2026
$1.7M
National Aeronautics and Space Administration (NASA) NNX17AE49GNIBIB NIH HHS T32 EB014836U.S. Department of Health & Human Services | National Institutes of Health (NIH) NIBIB 2T32EB014836
6 · The paper itself

Abstract

Natural killer (NK) cells are an important first-line of defense against malignant cells. Because of the potential for increased cancer risk from astronaut exposure to space radiation, we determined whether microgravity present during spaceflight affects the body's defenses against leukemogenesis. Human NK cells were cultured for 48 h under normal gravity and simulated microgravity (sμG), and cytotoxicity against K-562 (CML) and MOLT-4 (T-ALL) cells was measured using standard methodology or under continuous sμG. This brief exposure to sμG markedly reduced NK cytotoxicity against both leukemias, and these deleterious effects were more pronounced in continuous sμG. RNA-seq performed on NK cells from two additional healthy donors provided insight into the mechanism(s) by which sμG reduced cytotoxicity. Given our prior report of space radiation-induced human T-ALL in vivo, the reduced cytotoxicity against MOLT-4 is striking and raises the possibility that μG may increase astronaut risk of leukemogenesis during prolonged missions beyond LEO.

Identifiers

PMID39143086
PMCPMC11324864

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.